The Psychedelic Drugs Currently Under Investigation for Potential FDA Approval

Pharmacy Times interviewed Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), on psychedelic medicine policy and current advancements in the field.

During the discussion, Ali addressed which psychedelic drugs are currently under investigation for potential FDA approval, whether cannabis is considered a psychedelic drug, and whether the FDA has approved and acknowledged the use of cannabis as a medical treatment.